Niva Bupa Health Insurance Company Limited has completed the allotment of equity shares under its Employee Stock Option Plan, marking another milestone in its employee compensation strategy. The health insurance company informed the stock exchanges about this corporate action through an official communication dated March 05, 2026.

Share Allotment Details

The company has allotted a total of 2,58,200 equity shares to eligible employees under the Niva Bupa Employee Stock Option Plan 2020. The allotment took place on March 05, 2026, following the exercise of stock options by qualified grantees within the organization.

Regulatory Compliance

The allotment was conducted in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has duly informed both the National Stock Exchange of India Limited and BSE Limited about this corporate action through proper regulatory channels.

Share Rights and Privileges

The newly allotted equity shares will rank pari-passu with the existing equity shares of the company. This means that the new shareholders will enjoy equal rights and privileges as existing equity shareholders, including voting rights, dividend entitlements, and other corporate benefits as per the company's articles of association.

Company Information

Niva Bupa Health Insurance Company Limited operates under IRDAI Registration No. 145 and holds CIN: L66000DL2008PLC182918. The company maintains its registered office at C-98, First Floor, Lajpat Nagar, Part 1, New Delhi-110024, while its corporate office is located at 3rd Floor, Capital Cyber scape, Golf Course Extension Road, Sector-59, Gurugram-122101, Haryana.

Niva bupa health insurance company Limited has received a Show Cause Notice (SCN) and Letter of advice from the Insurance Regulatory and Development Authority of India (IRDAI) following a regulatory inspection. The company disclosed this development to stock exchanges on February 27, 2026, as required under SEBI listing regulations.

Regulatory Inspection and Subsequent Actions

IRDAI conducted an inspection of the company during February 2025, following which it issued observations that were duly replied to by the company. On February 26, 2026, at 1751 Hrs (IST), IRDAI issued both the Show Cause Notice and Letter of advice via email. The SCN relates to business and operational aspects of the company, while the Letter of advice provides compliance measures that the company must implement.

Nature of Violations Identified

The regulatory action stems from violations of certain provisions across multiple IRDAI master circulars:

Company's Response and Impact Assessment

The company is currently in the process of submitting its response to IRDAI regarding the Show Cause Notice. Additionally, Niva Bupa Health Insurance is implementing necessary actions as advised in the Letter of advice to ensure compliance with regulatory requirements.

Regulatory Compliance Disclosure

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure includes detailed annexures providing comprehensive information about the regulatory communication, including the nature of violations and the company's response measures. Company Secretary and Compliance Officer Aparna Sharma signed the disclosure, confirming that the information provided is true, correct, and complete to the best of the company's knowledge and belief.

The company emphasized that there is no impact on financial, operational, or other activities arising from this regulatory action at this stage, and it remains committed to implementing the necessary compliance measures as advised by IRDAI.